SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced the expansion of its relationship with the Città della Salute e della Scienza di Torino located in Turin, Italy. The hospital, which used SOPHiA GENETICS after a public tender in 2021 to optimize workflows and support research in the areas of hereditary cancer, neurological disorders, solid tumors, hematology and rare disease, will further expand its usage
Tomorrow, Tuesday February 28, 2023, occurs all over the world day dedicated to Rare Diseases (Rare Desease Day). The term “rare diseases” indicates those clinical conditions whose prevalence in the population is less than 5 cases per 10,000 inhabitants. In Italy rare patients are about 2 million and 70% of cases are pediatric patients. 5%…